Zacks Investment Research on MSN
Revvity develops high-throughput T-SPOT.TB platform for clinical labs
Revvity, Inc. RVTY recently announced the development of the T-SPOT A201, a next-generation high-throughput automated ...
LANDSTUHL, Germany – Landstuhl Regional Medical Center recently introduced a high-throughput testing system to provide rapid high-volume testing of COVID-19 samples to its arsenal in the fight against ...
The COVID-19 pandemic continues to rage, with more than five million deaths worldwide. The urgent, global nature of the pandemic has led to great innovation with novel vaccines and diagnostics, ...
As part of Healthy Davis Together, we have implemented rapid, inexpensive, high throughput testing for SARS-Cov-2 using technology repurposed from the agricultural biotechnology sector. This is ...
COVID 19 is caused by a new coronavirus , SARS-CoV-2, which is highly infectious and can cause a wide spectrum of symptoms and affect multiple human systems. What we have learned from other viral ...
Revvity, Inc. today announced the development of the T-SPOT™ A201, a next-generation high-throughput automated platform ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results